Where is the live CopyMark page for USPTO serial 79020376?

The live record is at https://getcopymark.com/trademark/79020376. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79020376?

According to the public USPTO record for serial number 79020376, the listed owner(s) include: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG.

What is USPTO serial number 79020376?

Serial number 79020376 is the USPTO application identifier for the mark Serial No. 79020376. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79020376?

Serial No. 79020376 (79020376) currently shows USPTO status code 402 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79020376?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79020376 Serial# 79020376 | status 402; last event RNWL | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79020376?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genitourinary system, the respiratory system, and dermatological disorders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cytostatic preparations for use in the treatment of cancer	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 18, 2025	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Mar 20, 2023	FINP	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Dec 9, 2022	XXSS	GENERIC MADRID TRANSACTION SENT TO IB	—
Dec 9, 2022	XXCR	GENERIC MADRID TRANSACTION CREATED	—
Jan 3, 2016	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Sep 25, 2009	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Jun 11, 2009	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
Oct 4, 2007	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Aug 17, 2007	OPNX	NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB	—
Aug 7, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2007	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Aug 2, 2007	OPNR	NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB	—
Jul 18, 2007	NPUB	NOTICE OF PUBLICATION	—
Jul 2, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Jul 2, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jun 8, 2007	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jun 7, 2007	ALIE	ASSIGNED TO LIE	—
May 21, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 21, 2007	MAIL	PAPER RECEIVED	—
Nov 22, 2006	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2006	MAIL	PAPER RECEIVED	—
Oct 31, 2006	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Oct 19, 2006	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 19, 2006	MAIL	PAPER RECEIVED	—
Jun 29, 2006	RFNT	REFUSAL PROCESSED BY IB	—
Jun 7, 2006	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jun 7, 2006	RFRR	REFUSAL PROCESSED BY MPU	—
Jun 7, 2006	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jun 6, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2006	DOCK	ASSIGNED TO EXAMINER	—
Mar 6, 2006	NWAP	NEW APPLICATION ENTERED	—
Mar 2, 2006	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79020376